These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6260109)
1. Role of the intestinal flora in the metabolism of misonidazole. Koch RL; Beaulieu BB; Goldman P Biochem Pharmacol; 1980 Dec; 29(24):3281-4. PubMed ID: 6260109 [No Abstract] [Full Text] [Related]
2. Histamine and 5-hydroxytryptamine in the intestinal tract of germ-free animals, animals harbouring one microbial species and conventional animals. BEAVER MH; WOSTMANN BS Br J Pharmacol Chemother; 1962 Dec; 19(3):385-93. PubMed ID: 13970018 [TBL] [Abstract][Full Text] [Related]
3. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats. Shoemaker D; Upton D; Strong J Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761 [TBL] [Abstract][Full Text] [Related]
4. Reduction of nitroheterocyclic compounds by mammalian tissues in vivo. Yeung TC; Sudlow G; Koch RL; Goldman P Biochem Pharmacol; 1983 Jul; 32(14):2249-53. PubMed ID: 6870947 [TBL] [Abstract][Full Text] [Related]
5. Studies on the O-demethylation of misonidazole by rat liver microsomes. Shoemaker DD; McManus ME; Hoerauf R; Strong JM Cancer Treat Rep; 1982 Jun; 66(6):1343-7. PubMed ID: 7083238 [TBL] [Abstract][Full Text] [Related]
6. Phenytoin-misonidazole: possible metabolic interaction. Gangji D; Schwade JG; Strong JM Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050 [TBL] [Abstract][Full Text] [Related]
7. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system. Smith BR; Born JL; Garcia DJ Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog. White RA; Workman P Cancer Treat Rep; 1980; 64(2-3):360-1. PubMed ID: 7190871 [No Abstract] [Full Text] [Related]
9. Kinetics of misonidazole enantiomers. Williams KM Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361 [TBL] [Abstract][Full Text] [Related]
10. Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases--glyoxal formation from misonidazole. Raleigh JA; Liu SF Biochem Pharmacol; 1983 Apr; 32(8):1444-6. PubMed ID: 6687998 [No Abstract] [Full Text] [Related]
11. The pharmacokinetics of misonidazole in the dog. White RA; Workman P; Freedman LS; Owen LN; Bleehen NM Eur J Cancer (1965); 1979 Oct; 15(10):1233-42. PubMed ID: 520395 [No Abstract] [Full Text] [Related]
12. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)]. Akel G; Canal P; Bugat R; Soula G; Combes PF J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-enhanced reduction and covalent binding of [2-3H]misonidazole in the perfused rat liver. Smith BR Biochem Pharmacol; 1984 Apr; 33(8):1379-81. PubMed ID: 6201179 [No Abstract] [Full Text] [Related]
14. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice. Chin JB; Rauth AM Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696 [No Abstract] [Full Text] [Related]